© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
December 08, 2021
Influenza is expected to make a comeback this year, and no one knows
how severe it may be.
October 18, 2021
Seqirus’s FLUCELVAX® cell-based quadrivalent influenza vaccine has been approved to expand the age indication to children as young as 6 months of age by the US Food and Drug Administration.
October 15, 2021
According to new survey data from the National Foundation for Infectious Diseases, nearly 1 in 4 people at high risk for flu-related complications, such as pregnant women, did not plan to get vaccinated.
September 09, 2021
Novavax Incorporation announced on Monday that its combined flu and COVID-19 vaccine elicited working antibodies against the viruses in a preclinical study.
August 11, 2021
Although COVID-19 safety measures helped squash the number of influenza cases last season, pharmacists are revving up vaccination programs and testing.
June 04, 2021
A study highlighted at the 2021 ASCO Annual Meeting explored whether patients who received an influenza vaccine were at increased risk for immune-related adverse events from single-agent immune checkpoint inhibitors.
May 25, 2021
In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.
March 24, 2021
A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity
February 11, 2021
Preventive efforts, renewed interest in vaccinations drive milder flu season.
February 04, 2021
Peramivir injection (Rapivab; BioCryst) is approved for use in patients aged 6 months and older.